Gilead Sciences Announces 10 Percent Increase in First Quarter 2018 Dividend

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 10% in the company’s quarterly cash dividend, beginning in the first quarter of 2018. The dividend increase will result in a quarterly dividend of $0.57 per share of common stock. The dividend is payable on March 29, 2018, to stockholders of record at the close of business on March 16, 2018. Future dividends will be subject to Board approval.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180206005928/en/

Gilead Sciences, Inc.
Investors
Robin Washington, 650-522-5688
Sung Lee, 650-524-7792

Source: Gilead Sciences, Inc.

You May Also Be Interested In

• Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald: Yeztugo Total TRx Down
• U.S. News Unveils Inaugural 2026-2027 Best Conference Cities and Best Conference Hotels
• Rebuilders International Announces Amazon Best Seller Recognition for 10 Week Divorce Recovery, a Data Driven Roadmap Built from Thousands of Real Recovery Stories